Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.

Khan QJ, Bohnenkamp C, Monson TE, Phadnis MA, Clark L, Smith HE, Raja V, Elia M, O'Dea A, Fesen MR, Crane GJ, Nye LE, Baranda JC, Pluenneke RE, Hoffmann M, Al-Rajabi RMT, Kasi A, McKittrick RJ, Mitchell L, LaFaver S, Sharma P

Open source

DOI: 10.1200/oa-24-00068
Published: 2025
Container: JCO oncology advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/oa-24-00068,
  title = {Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.},
  author = {Khan QJ and Bohnenkamp C and Monson TE and Phadnis MA and Clark L and Smith HE and Raja V and Elia M and O'Dea A and Fesen MR and Crane GJ and Nye LE and Baranda JC and Pluenneke RE and Hoffmann M and Al-Rajabi RMT and Kasi A and McKittrick RJ and Mitchell L and LaFaver S and Sharma P},
  year = {2025},
  journal = {JCO oncology advances},
  doi = {10.1200/oa-24-00068},
  url = {https://doi.org/10.1200/oa-24-00068}
}

RIS

TY  - JOUR
TI  - Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.
AU  - Khan QJ
AU  - Bohnenkamp C
AU  - Monson TE
AU  - Phadnis MA
AU  - Clark L
AU  - Smith HE
AU  - Raja V
AU  - Elia M
AU  - O'Dea A
AU  - Fesen MR
AU  - Crane GJ
AU  - Nye LE
AU  - Baranda JC
AU  - Pluenneke RE
AU  - Hoffmann M
AU  - Al-Rajabi RMT
AU  - Kasi A
AU  - McKittrick RJ
AU  - Mitchell L
AU  - LaFaver S
AU  - Sharma P
PY  - 2025
JO  - JCO oncology advances
DO  - 10.1200/oa-24-00068
UR  - https://doi.org/10.1200/oa-24-00068
ER  -

APA

QJ, K., C, B., TE, M., MA, P., L, C., HE, S., V, R., M, E., A, O., MR, F., GJ, C., LE, N., JC, B., RE, P., M, H., RMT, A., A, K., RJ, M., L, M., S, L., & P, S. (2025). Randomized Trial of Fixed-Dose Capecitabine Compared With Standard-Dose Capecitabine in Metastatic Breast Cancer: X-7/7 Trial.. JCO oncology advances. https://doi.org/10.1200/oa-24-00068

Source records

pubmed · retrieved 2026-09-27T00:36:13.280Z